Sample characteristics of survey respondents. by Fabrice Etilé (4741332)

Subjects:

Distribution of willingness to risk exposure by COVID-negative status. by Fabrice Etilé (4741332)

Subjects:

Effect heterogeneity by trust and family orientation. by Fabrice Etilé (4741332)

Subjects:

Impact of economic conditions, COVID-19 risk beliefs and anxiety. by Fabrice Etilé (4741332)

Subjects:

Distribution of status anxiety scores. by Fabrice Etilé (4741332)

Subjects:

Beliefs about COVID-19. by Fabrice Etilé (4741332)

Subjects:

Mean scores, standard deviations, and significance on key measures and subscales by gender group. by Silas Manning (22693338)

Machine Learning Model Performance Sorted by Decreasing MAE. by Renan N. D. Almeida (9265283)

Significant decrease of the viability of A375 melanoma cells after CD treatment. by Lena Berning (7430117)

Comparing demographic data (mean values). by Tamer Shousha (10960632)

Subjects:

Estimated annual variation in predicted skin lesion point prevalence by pod. by Joseph K. Gaydos (8830838)

Points represent regions where the cluster coefficient was significantly larger in HC compared to MCI, at sparsity level of 0.15. by Therese M. Gilligan (7460906)

The body weight and cholesterol levels of the mice were recorded before the administration of the drug. by Xueqin lu (22250795)

Subjects:

Effects of Kylo-0603 on body weight, organ weight, and body fat content. by Xueqin lu (22250795)

Subjects:

After 8 weeks of treatment, body fat analysis and bone mineral density testing of mice in each group. by Xueqin lu (22250795)

Subjects:

Pharmacological efficacy of Kylo-0603 in MASH mouse models (F2 ~ 3). by Xueqin lu (22250795)

Subjects:

The Chol and TG content in liver homogenates of the mice in each group after 2 and 10 weeks of drug intervention. by Xueqin lu (22250795)

Subjects:

Plasma cholesterol and LDL-C levels. by Xueqin lu (22250795)

Subjects:

Hematoxylin and eosin (H&E) staining, Sirius Red staining, and Oil Red staining of liver tissues from mice in each group after 8 weeks of treatment with either vehicle or Kylo-0603... by Xueqin lu (22250795)

Subjects:

Feasibility diagram of design points. by Xueyong Pan (20390363)

“…The <i>T</i>_max of the battery module decreased by 6.84% from 40.94°C to 38.14°C and temperature mean square deviation decreased (<i>TSD</i>) by 62.13% from 1.69 to 0.64. …”